281 related articles for article (PubMed ID: 11593364)
1. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors.
Cui FD; Kishida T; Ohashi S; Asada H; Yasutomi K; Satoh E; Kubo T; Fushiki S; Imanishi J; Mazda O
Gene Ther; 2001 Oct; 8(19):1508-13. PubMed ID: 11593364
[TBL] [Abstract][Full Text] [Related]
2. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
[TBL] [Abstract][Full Text] [Related]
3. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.
Liu F; Song Y; Liu D
Gene Ther; 1999 Jul; 6(7):1258-66. PubMed ID: 10455434
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice.
Tsukamoto H; Wells D; Brown S; Serpente P; Strong P; Drew J; Inui K; Okada S; Dickson G
Gene Ther; 1999 Jul; 6(7):1331-5. PubMed ID: 10455444
[TBL] [Abstract][Full Text] [Related]
5. Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer.
Harada Y; Iwai M; Tanaka S; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
Cancer Gene Ther; 2000 Jan; 7(1):27-36. PubMed ID: 10678353
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice.
Sclimenti CR; Neviaser AS; Baba EJ; Meuse L; Kay MA; Calos MP
Biotechnol Prog; 2003; 19(1):144-51. PubMed ID: 12573017
[TBL] [Abstract][Full Text] [Related]
7. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of naked DNA uptake and expression.
Wolff JA; Budker V
Adv Genet; 2005; 54():3-20. PubMed ID: 16096005
[TBL] [Abstract][Full Text] [Related]
9. Time course of gene expression after plasmid DNA gene transfer to the liver.
Herweijer H; Zhang G; Subbotin VM; Budker V; Williams P; Wolff JA
J Gene Med; 2001; 3(3):280-91. PubMed ID: 11437333
[TBL] [Abstract][Full Text] [Related]
10. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes.
Saeki Y; Wataya-Kaneda M; Tanaka K; Kaneda Y
Gene Ther; 1998 Aug; 5(8):1031-7. PubMed ID: 10326025
[TBL] [Abstract][Full Text] [Related]
11. A novel nonviral cytoplasmic gene expression system and its implications in cancer gene therapy.
Chen X; Li Y; Xiong K; Xie Y; Aizicovici S; Snodgrass R; Wagner TE; Platika D
Cancer Gene Ther; 1995 Dec; 2(4):281-9. PubMed ID: 8548582
[TBL] [Abstract][Full Text] [Related]
12. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
[TBL] [Abstract][Full Text] [Related]
13. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
[TBL] [Abstract][Full Text] [Related]
15. Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo.
Nakanishi H; Mazda O; Satoh E; Asada H; Morioka H; Kishida T; Nakao M; Mizutani Y; Kawauchi A; Kita M; Imanishi J; Miki T
Gene Ther; 2003 Mar; 10(5):434-42. PubMed ID: 12601398
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system.
Nishikawa M; Yamauchi M; Morimoto K; Ishida E; Takakura Y; Hashida M
Gene Ther; 2000 Apr; 7(7):548-55. PubMed ID: 10819569
[TBL] [Abstract][Full Text] [Related]
17. High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine.
Tada M; Hatano E; Taura K; Nitta T; Koizumi N; Ikai I; Shimahara Y
J Gene Med; 2006 Aug; 8(8):1018-26. PubMed ID: 16779866
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus/human vector provides high-level, long-term expression of alpha1-antitrypsin in mice.
Stoll SM; Sclimenti CR; Baba EJ; Meuse L; Kay MA; Calos MP
Mol Ther; 2001 Aug; 4(2):122-9. PubMed ID: 11482983
[TBL] [Abstract][Full Text] [Related]
19. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer.
Maruyama-Tabata H; Harada Y; Matsumura T; Satoh E; Cui F; Iwai M; Kita M; Hibi S; Imanishi J; Sawada T; Mazda O
Gene Ther; 2000 Jan; 7(1):53-60. PubMed ID: 10680016
[TBL] [Abstract][Full Text] [Related]
20. Successful genetic transduction in vivo into synovium by means of electroporation.
Ohashi S; Kubo T; Kishida T; Ikeda T; Takahashi K; Arai Y; Terauchi R; Asada H; Imanishi J; Mazda O
Biochem Biophys Res Commun; 2002 May; 293(5):1530-5. PubMed ID: 12054690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
